Study to Characterize Absorption, Distribution, Metabolism and Excretion of 14C PF-06651600 and to Evaluate the Absolute Oral Bioavailability and Fraction Absorbed of PF-06651600.
Clinical trial NCT03929510 · COMPLETED
Trial details
- NCT number
- NCT03929510
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-23
- Primary completion
- 2019-07-05
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.